McKesson Compile Unveils New Research Revealing the Impact of Real-World Data Volatility for Biopharma Companies​

Survey finds nearly 70% of commercial leaders in biopharma companies have encountered volatility in real-world claims data in the past year

McKesson Compile™, a leading provider of analytics-ready data and tailored intelligence to life science companies, today released a survey report, How Claims Data Volatility is Impacting Biopharma: A 2025 Industry Snapshot. The survey revealed the far-reaching impact of data disruptions on biopharma companies.

Volatility in real-world claims data, caused by factors such as cyberattacks and changes in source data vendor strategy, has become a growing issue. To understand how data volatility affects the professionals working to bring potentially life-saving drugs and vaccines to market, McKesson Compile conducted a survey of 75 biopharma commercial leaders who regularly work with medical or prescription claims data. Key findings from the report include:

• 68% of respondents encountered data volatility in the past year, and 99% worry about future disruptions.
• 98% of respondents who experienced volatility reported increased job stress.
• 73% of respondents who experienced volatility drew false insights as a result of inconsistent or incomplete data.
• 71% of respondents have changed or plan to change their data vendor management process to mitigate future disruptions.

“In a rapidly evolving drug development landscape, commercialization strategies depend on accurate and timely data-driven insights,” said Olivia vonNieda, Vice President and General Manager, McKesson Compile. “This research confirms what many in the industry have experienced firsthand: that undetected data issues can compromise critical business decisions. At McKesson Compile, we combine reliable data products with transparency and proactive support in service of helping our customers navigate a complex data landscape.”

The report outlines specific actions biopharma companies are taking to strengthen their data sourcing strategies, along with practical approaches for evaluating vendors based on transparency and proactive communication.

Access the full report here.